Anxo Pharmaceutical Co., Ltd. (TPEX:6677)

Market Cap	988.92M +4.8%
Revenue (ttm)	843.26M -5.8%
Net Income	-34.13M
EPS	-0.61
Shares Out	55.87M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	53,350
Open	17.70
Previous Close	17.70
Day's Range	17.30 - 17.70
52-Week Range	16.30 - 30.50
Beta	0.38
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 13, 2026

About Anxo Pharmaceutical

Anxo Pharmaceutical Co., Ltd., a specialty pharmaceutical company, develops, manufactures, and sells pharmaceutical products for medical professionals and patients in Taiwan and internationally. The company offers prescription and over the counter drugs in various therapeutic areas, such as cardiovascular, metabolism, CNS, diabetic, respiratory, anti-infection, dermatology, nephrology, urology, orthopedics, etc. It also offers drugs for antidiabetic/dyslipidaemic agents, cardiovascular/circulatory system, nervous system, hepatology/gastroentero...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2003
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6677

Financial Performance

In 2025, Anxo Pharmaceutical's revenue was 843.26 million, a decrease of -5.81% compared to the previous year's 895.32 million. Losses were -34.13 million, -40.34% less than in 2024.